Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

2 Eli Lilly FDA Plays With Great Potential And Limited Downside
Seeking Alpha
Wednesday, February 29, 2012 - 4:49pm
tags:
Eli Lilly, FDA, solanezumab, Alzheimer's disease
HGSI Narrows 4Q Loss, Benlysta Grows
Yahoo/Zacks
Wednesday, February 29, 2012 - 4:47pm
tags:
earnings, Human Genome Sciences
Why Eli Lilly's Earnings Are Outstanding
Motley Fool
Wednesday, February 29, 2012 - 11:54am
tags:
earnings, Eli Lilly
Will FDA Delay Approving The Eliquis Bloodthinner?
Pharmalot
Wednesday, February 29, 2012 - 11:08am
tags:
FDA, bloodthinners, Eliquis
Threshold Pharmaceuticals: Understanding The Recent Data
Seeking Alpha
Wednesday, February 29, 2012 - 11:07am
tags:
Threshold Pharmaceuticals, TH-302, pancreatic cancer
ViroPharma Beats Up on Analysts Yet Again
Motley Fool
Wednesday, February 29, 2012 - 11:06am
tags:
ViroPharma, earnings
Why Illumina's Earnings Are Outstanding
Motley Fool
Wednesday, February 29, 2012 - 11:05am
tags:
Illumina, earnings
Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug
Seeking Alpha
Wednesday, February 29, 2012 - 11:04am
tags:
Arena Pharmaceuticals, lorcaserin, Vivus, Qnexa, obesity
Cerus shares jump on strong 4th-qtr sales
Reuters
Wednesday, February 29, 2012 - 11:03am
tags:
earnings, Cerus
Galapagos looking for acquisitions after drug deal
Reuters
Wednesday, February 29, 2012 - 11:02am
tags:
Abbott Laboratories, M&A, Galapagos
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Bloomberg
Wednesday, February 29, 2012 - 10:12am
tags:
obesity, M&A, Vivus, Qnexa, JNJ, Merck, Bristol-Myers Squibb, Arena Pharmaceuticals, Orexigen
Study Suggests a Link Between Sleeping Pills, Early Death
WSJ Online
Wednesday, February 29, 2012 - 10:10am
tags:
insomnia, sleep aid, early death
Don't Count Vertex Out Just Yet
Motley Fool
Wednesday, February 29, 2012 - 10:09am
tags:
Vertex, Incivek, hepatitis C, Merck, Roche
Pfizer recalls expired lot of Prevnar vaccine
Reuters
Wednesday, February 29, 2012 - 10:07am
tags:
Pfizer, recalls, vaccines, Prevnar
Ariad shares fall after posting wider 4th-qtr loss
Yahoo/AP
Wednesday, February 29, 2012 - 10:07am
tags:
earnings, Ariad Pharmaceuticals
4-Star Stocks Poised to Pop: Bristol-Myers
Motley Fool
Wednesday, February 29, 2012 - 10:06am
tags:
Bristol-Myers Squibb
IPO Preview: Argos Therapeutics
Seeking Alpha
Wednesday, February 29, 2012 - 10:05am
tags:
IPOs, Argos, GSK, Novartis, Pfizer, ONYX Pharmaceuticals
Ampio: On The Trail Of An Osteoarthritis Winner
Seeking Alpha
Wednesday, February 29, 2012 - 10:04am
tags:
Ampio, osteoarthritis, Ampion
Merck Warned by FDA on Failure to Study Januvia Treatment for Side Effects
Bloomberg
Tuesday, February 28, 2012 - 1:46pm
tags:
FDA, Januvia, Merck, Janumet, diabetes
Heinz Eyes Pfizer's Baby Food
Yahoo/Zacks
Tuesday, February 28, 2012 - 1:45pm
tags:
Pfizer, infant nutrition, Heinz

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.